Rapid desensitization to elexacaftor/tezacaftor/ivacaftor in a cystic fibrosis patient using fatty snack for improved absorption

被引：1
|
作者：
Ali, Irfan [1 ]
Kalkat, Amanpreet [1 ]
Hostoffer, Robert [1 ]
机构：
[1] Univ Hosp, Cleveland Med Ctr, Cleveland, OH 44106 USA
来源：
PEDIATRIC PULMONOLOGY | 2023年 / 58卷 / 10期
关键词：
cystic fibrosis; elexacaftor/tezacaftor/ivacaftor;
D O I：
10.1002/ppul.26609
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：2954 / 2955
页数：2
相关论文
共 50 条
  • [21] Elexacaftor/tezacaftor/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis
    Cavinato, Luca
    Luly, Francesco R.
    Pastore, Valentina
    Chiappetta, Daniele
    Sangiorgi, Gloria
    Ferrara, Eva
    Baiocchi, Pia
    Mandarello, Giuseppe
    Cimino, Giuseppe
    Del Porto, Paola
    Ascenzioni, Fiorentina
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (04)
  • [22] Characterization of sleep in emerging adults with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor
    Meltzer, Lisa J.
    Gross, Jane E.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 132 - 136
  • [23] Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease
    Djavid, Amir Reza
    Thompson, Alison E.
    Irace, Alexandria L.
    Gusman, Elen
    Altman, Kimberly
    DiMango, Emily A.
    Keating, Claire L.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (11) : 1924 - 1927
  • [24] Elexacaftor-tezacaftor-ivacaftor overdose in an adolescent female with cystic fibrosis
    Lyman, Benjamin C.
    Seay, Jessica
    Contreary, Casey
    Savant, Adrienne P.
    Dell, Mary Lynn
    Hescock, George C.
    PEDIATRIC PULMONOLOGY, 2022, 57 (12) : 3174 - 3176
  • [25] Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis
    Tewkesbury, Daniel H.
    Scott, Jennifer
    Barry, Peter J.
    Bright-Thomas, Rowland J.
    Hanley, Karen Piper
    Athwal, Varinder
    Jones, Andrew M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 349 - 353
  • [26] EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS
    Portolese, Olivia
    Bilodeau, Marc
    Castel, Helene
    Willems, Bernard E.
    Huard, Genevieve
    Vincent, Catherine
    Lavoie, Annick
    Hercun, Julian
    HEPATOLOGY, 2023, 78 : S638 - S639
  • [27] Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftor
    Sanders, Don B.
    Mayer-Hamblett, Nicole
    Rosenfeld, Margaret
    Polinieni, Deepika
    Dasenbrook, Elliott
    Szczesniak, Rhonda
    Cromwell, Elizabeth A.
    JOURNAL OF CYSTIC FIBROSIS, 2025, 24 (02) : 255 - 262
  • [28] Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis
    Stapleton, Amanda L.
    Kimple, Adam J.
    Goralski, Jennifer L.
    Nouraie, S. Mehdi
    Branstetter, Barton F.
    Shaffer, Amber
    Pilewski, Joseph M.
    Senior, Brent A.
    Lee, Stella E.
    Zemke, Anna C.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (05) : 792 - 799
  • [29] The impact of elexacaftor/tezacaftor/ivacaftor on adherence to maintenance therapies in cystic fibrosis
    Johnson, Ellie
    Land, Rachel
    Reid, David
    RESPIROLOGY, 2024, 29 : 7 - 7
  • [30] Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis
    Donaldson, Scott H.
    Corcoran, Timothy E.
    Pilewski, Joseph M.
    Mogayzel, Peter
    Laube, Beth L.
    Boitet, Evan R.
    Harris, Elex S.
    Ceppe, Agathe
    Edwards, Lloyd J.
    Zeman, Kirby
    Wu, Jihong
    Esther, Charles R.
    Nichols, David P.
    Bennett, William D.
    Rowe, Steven M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 155 - 160
12345